These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 24855912

  • 1. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T, Nakamura S, Imamura Y, Yoshioka S, Miyazaki T, Izumikawa K, Sawai T, Matsuo N, Yanagihara K, Suyama N, Kohno S.
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [Abstract] [Full Text] [Related]

  • 2. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
    Hagiwara A, Tanaka N, Uemura T, Matsuda W, Kimura A.
    BMJ Open; 2016 Dec 30; 6(12):e012850. PubMed ID: 28039291
    [Abstract] [Full Text] [Related]

  • 3. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
    Yoshimura J, Yamakawa K, Ogura H, Umemura Y, Takahashi H, Morikawa M, Inoue Y, Fujimi S, Tanaka H, Hamasaki T, Shimazu T.
    Crit Care; 2015 Mar 03; 19(1):78. PubMed ID: 25883031
    [Abstract] [Full Text] [Related]

  • 4. The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study.
    Yoshihara M, Uno K, Tano S, Mayama M, Ukai M, Kondo S, Kokabu T, Kishigami Y, Oguchi H.
    Crit Care; 2015 Oct 20; 19():369. PubMed ID: 26481315
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
    Yasuda N, Goto K, Ohchi Y, Abe T, Koga H, Kitano T.
    J Crit Care; 2016 Dec 20; 36():29-34. PubMed ID: 27546744
    [Abstract] [Full Text] [Related]

  • 7. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
    Akahoshi T, Sugimori H, Kaku N, Tokuda K, Nagata T, Noda E, Morita M, Hashizume M, Maehara Y.
    Eur J Trauma Emerg Surg; 2015 Oct 20; 41(5):531-8. PubMed ID: 26038004
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
    Hayakawa M, Yamakawa K, Saito S, Uchino S, Kudo D, Iizuka Y, Sanui M, Takimoto K, Mayumi T, Ono K, Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study group.
    Thromb Haemost; 2016 Jun 02; 115(6):1157-66. PubMed ID: 26939575
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Factors Determining the Efficacy of Recombinant Human Thrombomodulin in the Treatment of Sepsis-Induced Disseminated Intravascular Coagulation.
    Kotake K, Hongo T, Tahira A, Niimi N, Haisa I, Kawakami Y.
    Biol Pharm Bull; 2021 May 01; 44(5):605-610. PubMed ID: 33612566
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - A meta-analysis.
    Kato H, Hagihara M, Asai N, Umemura T, Hirai J, Mori N, Yamagishi Y, Iwamoto T, Mikamo H.
    Thromb Res; 2023 Jun 01; 226():165-172. PubMed ID: 37182388
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC.
    Aota T, Wada H, Yamashita Y, Matsumoto T, Ohishi K, Suzuki K, Imai H, Usui M, Isaji S, Katayama N.
    Int J Hematol; 2016 Feb 01; 103(2):173-9. PubMed ID: 26590919
    [Abstract] [Full Text] [Related]

  • 15. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T, Kohno Y, Koishi K.
    Am J Emerg Med; 2012 Sep 01; 30(7):1219-23. PubMed ID: 22204993
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.